Clinical trials query results
From Health Canada
- Medical condition:
- POST-TRAUMATIC STRESS DISORDER
- Medical condition:
- ADULT FEMALE,ADULT MALE
- Drug name:
- PSILOCYBIN
- Protocol title:
- INVESTIGATING THE THERAPEUTIC EFFECT OF PSILOCYBIN IN TREATMENT-RESISTANT POST-TRAUMATIC STRESS DISORDER (PTSD)
- Sponsor name:
- HALUCENEX LIFE SCIENCES INC
- Date of no objection letter:
- 2022-02-23
- Control number:
- 260668
- Trial status:
- CLOSED
- Date study started:
- 2023-01-09
- Date study completed:
- 2024-02-01